Cancer Therapies

Clinical Results of Cancer Drug Presented

Published in Cancer Weekly, June 1st, 1998

SunPharm Corp., Jacksonville, Florida, announced that data from its Phase I clinical trial of Diethylnorspermine (DENSPM), was presented at the American Society of Clinical Oncologists (ASCO) annual conference, held in Los Angeles, California, during May 1998.

David Ettinger, M.D., Johns Hopkins Oncology Center, Baltimore, Maryland, and a lead clinical investigator, presented Phase I study results of SunPharm's cancer drug, DENSPM. The results demonstrated that the compound was well tolerated in late stage lung cancer patients refractory to all conventional chemotherapy.

Based on these results, Warner-Lambert initiated multicenter Phase II studies...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1998-06-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry